Xarelto (zah-rel-toe) is the latest ORAL anticoagulant to hit the Canadian market
November 2008
Xarelto (zah-rel-toe) is the latest ORAL anticoagulant to hit the Canadian market...just a few months after Pradax.
Both will be used as alternatives to low-molecular-weight heparin (Lovenox, etc)...to prevent clots after knee or hip replacement.
Patients will take Xarelto 10 mg orally once daily...for 14 days after a knee replacement or 35 days after a hip replacement.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive